Rapid viral suppression using integrase inhibitors during acute HIV-1 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 169, doi. 10.1093/jac/dkae391
- By:
- Publication type:
- Article
Works matching AU McGee, Kara S
Results: 5
1
2
Dolutegravir/Abacavir/Lamivudine in Acute HIV-1 Results in Rapid Suppression and Restoration of CD4 T-cell Subsets Without Accelerated Decay of Latent HIV-1 Open Access.
- Published in:
- Open Forum Infectious Diseases, 2025, v. 12, n. 5, p. 1, doi. 10.1093/ofid/ofaf247
- By:
- Publication type:
- Article
3
Case Report: Reversal of Integrase Inhibitor– and Tenofovir Alafenamide–Related Weight Gain After Switching Back to Efavirenz/Emtricitabine/Tenofovir DF.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab403
- By:
- Publication type:
- Article
4
Canary in the Coal Mine? Transmitted Mutations Conferring Resistance to All Integrase Strand Transfer Inhibitors in a Treatment-Naive Patient.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy294
- By:
- Publication type:
- Article
5
Canary in the Coal Mine? Transmitted mutations conferring resistance to all integrase strand-transfer inhibitors in a treatment-naïve patient.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 10, p. N.PAG, doi. 10.1093/ofid/ofy294
- By:
- Publication type:
- Article